Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.
Standard
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. / Kuehn, Thorsten; Bauerfeind, Ingo; Fehm, Tanja; Fleige, Barbara; Hausschild, Maik; Helms, Gisela; Lebeau, Annette; Liedtke, Cornelia; von Minckwitz, Gunter; Nekljudova, Valentina; Schmatloch, Sabine; Schrenk, Peter; Staebler, Annette; Untch, Michael.
in: LANCET ONCOL, Jahrgang 14, Nr. 7, 7, 2013, S. 609-618.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.
AU - Kuehn, Thorsten
AU - Bauerfeind, Ingo
AU - Fehm, Tanja
AU - Fleige, Barbara
AU - Hausschild, Maik
AU - Helms, Gisela
AU - Lebeau, Annette
AU - Liedtke, Cornelia
AU - von Minckwitz, Gunter
AU - Nekljudova, Valentina
AU - Schmatloch, Sabine
AU - Schrenk, Peter
AU - Staebler, Annette
AU - Untch, Michael
PY - 2013
Y1 - 2013
N2 - The optimum timing of sentinel-lymph-node biopsy for breast cancer patients treated with neoadjuvant chemotherapy is uncertain. The SENTINA (SENTinel NeoAdjuvant) study was designed to evaluate a specific algorithm for timing of a standardised sentinel-lymph-node biopsy procedure in patients who undergo neoadjuvant chemotherapy.
AB - The optimum timing of sentinel-lymph-node biopsy for breast cancer patients treated with neoadjuvant chemotherapy is uncertain. The SENTINA (SENTinel NeoAdjuvant) study was designed to evaluate a specific algorithm for timing of a standardised sentinel-lymph-node biopsy procedure in patients who undergo neoadjuvant chemotherapy.
M3 - SCORING: Journal article
VL - 14
SP - 609
EP - 618
JO - LANCET ONCOL
JF - LANCET ONCOL
SN - 1470-2045
IS - 7
M1 - 7
ER -